Paper Details

  1. Home
  2. Paper Details

Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report.

Author: AngeliniAndrea, BallariniMelissa, DalmastriVittorio, GrammaticoFrancesco, La MannaGaetano, MinervaVera, PizziniAttilia Maria, SilingardiMauro, TodeschiniPaola

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This case report describes a patient successfully treated with extracorporeal hemoadsorption therapy using CytoSorb as an antidote for apixaban overdose to enable emergency surgery for bilateral nephrostomy. CytoSorb has shown promise in removing certain antithrombotic agents, potentially offering a solution for managing overdose or emergency situations involving NOACs.
Paper Details　
Original Abstract of the Article :
Apixaban is a non-vitamin K antagonist oral anticoagulant (NOACs) recently emerged as an effective alternative to conventional vitamin K antagonists (VKAs) in the treatment of several thromboembolic disorders. However, in case of overdose or in patients requiring emergency surgery there is a high bl...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327312/

データ提供：米国国立医学図書館（NLM）

Extracorporeal Hemoadsorption: A Life-Saving Oasis in the Desert of Medical Emergencies

The field of [anticoagulation] constantly seeks innovative solutions to manage complex medical situations. This case report sheds light on the potential of extracorporeal hemoadsorption therapy, a cutting-edge technique, to swiftly remove medications like Apixaban from the bloodstream, especially in life-threatening emergencies.

A Speedy Solution: Extracorporeal Hemoadsorption as a Life Raft in a Storm

The study describes the successful use of extracorporeal hemoadsorption therapy in a patient who required emergency surgery. The therapy effectively removed Apixaban, a potent anticoagulant, allowing for the safe completion of the surgical procedure.

Navigating the Waters of Medication Management: A Guiding Light

The research highlights the importance of having a readily available solution for managing anticoagulant overdoses. It's like having a life raft in a storm, offering a lifeline in emergencies. The study's findings encourage further research to investigate the efficacy and safety of extracorporeal hemoadsorption therapy across a wider range of clinical scenarios.

Dr.Camel's Conclusion

This case report offers a glimmer of hope in the desert of emergency medicine. Extracorporeal hemoadsorption therapy may serve as a vital tool for managing anticoagulant overdoses and enabling prompt medical interventions.

Date :
  1. Date Completed 2023-07-10
  2. Date Revised 2023-07-18
Further Info :

Pubmed ID

37415195

DOI: Digital Object Identifier

PMC10327312

Related Literature

Article Analysis
・Side Effects of apixaban
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.